Supramolecular bioconjugation strategy for antibody-targeted delivery of siRNA - DSA-IPHC
Article Dans Une Revue Bioconjugate Chemistry Année : 2024

Supramolecular bioconjugation strategy for antibody-targeted delivery of siRNA

Résumé

RNA interference is a widely used biological process by which double-stranded RNA induces sequence-specific gene silencing by targeting mRNA for degradation. However, the physicochemical properties of siRNAs make their delivery extremely challenging, thus limiting their bioavailability at the target site. In this context, we developed a versatile and selective siRNA delivery system of a trastuzumab-conjugated nanocarrier. These immunoconjugates consist of the assembly by electrostatic interactions of an oligonucleotide-modified antibody with a cationic micelle for the targeted delivery of siRNA in HER2-overexpressing cancer cells. Results show that, when associated with the corresponding siRNA at the appropriate N/P ratio, our supramolecular assembly was able to efficiently induce luciferase and PLK-1 gene silencing in a cell-selective manner in vitro.

Domaines

Chimie
Fichier principal
Vignette du fichier
ripoll-et-al-2024-supramolecular-bioconjugation-strategy-for-antibody-targeted-delivery-of-sirna.pdf (3.44 Mo) Télécharger le fichier
Origine Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-04728199 , version 1 (09-10-2024)

Identifiants

Citer

Manon Ripoll, Héloïse Cahuzac, Igor Dovgan, Sylvain Ursuegui, Patrick Neuberg, et al.. Supramolecular bioconjugation strategy for antibody-targeted delivery of siRNA. Bioconjugate Chemistry, 2024, Online ahead of print. ⟨10.1021/acs.bioconjchem.4c00304⟩. ⟨hal-04728199⟩
39 Consultations
9 Téléchargements

Altmetric

Partager

More